• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机化以防止医疗保健试验中的选择偏倚。

Randomisation to protect against selection bias in healthcare trials.

作者信息

Odgaard-Jensen Jan, Vist Gunn E, Timmer Antje, Kunz Regina, Akl Elie A, Schünemann Holger, Briel Matthias, Nordmann Alain J, Pregno Silvia, Oxman Andrew D

机构信息

Norwegian Knowledge Centre for the Health Services, PO Box 7004, St. Olavs Plass, Oslo, Norway, N-0130.

出版信息

Cochrane Database Syst Rev. 2011 Apr 13;2011(4):MR000012. doi: 10.1002/14651858.MR000012.pub3.

DOI:10.1002/14651858.MR000012.pub3
PMID:21491415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7150228/
Abstract

BACKGROUND

Randomised trials use the play of chance to assign participants to comparison groups. The unpredictability of the process, if not subverted, should prevent systematic differences between comparison groups (selection bias). Differences due to chance will still occur and these are minimised by randomising a sufficiently large number of people.

OBJECTIVES

To assess the effects of randomisation and concealment of allocation on the results of healthcare studies.

SEARCH STRATEGY

We searched the Cochrane Methodology Register, MEDLINE, SciSearch and reference lists up to September 2009. In addition, we screened articles citing included studies (ISI Science Citation Index) and papers related to included studies (PubMed).

SELECTION CRITERIA

Eligible study designs were cohorts of studies, systematic reviews or meta-analyses of healthcare interventions that compared random allocation versus non-random allocation or adequate versus inadequate/unclear concealment of allocation in randomised trials. Outcomes of interest were the magnitude and direction of estimates of effect and imbalances in prognostic factors.

DATA COLLECTION AND ANALYSIS

We retrieved and assessed studies that appeared to meet the inclusion criteria independently. At least two review authors independently appraised methodological quality and extracted information. We prepared tabular summaries of the results for each comparison and assessed the results across studies qualitatively to identify common trends or discrepancies.

MAIN RESULTS

A total of 18 studies (systematic reviews or meta-analyses) met our inclusion criteria. Ten compared random allocation versus non-random allocation and nine compared adequate versus inadequate or unclear concealment of allocation within controlled trials. All studies were at high risk of bias.For the comparison of randomised versus non-randomised studies, four comparisons yielded inconclusive results (differed between outcomes or different modes of analysis); three comparisons showed similar results for random and non-random allocation; two comparisons had larger estimates of effect in non-randomised studies than in randomised trials; and two comparisons had larger estimates of effect in randomised than in non-randomised studies.Five studies found larger estimates of effect in trials with inadequate concealment of allocation than in trials with adequate concealment. The four other studies did not find statistically significant differences.

AUTHORS' CONCLUSIONS: The results of randomised and non-randomised studies sometimes differed. In some instances non-randomised studies yielded larger estimates of effect and in other instances randomised trials yielded larger estimates of effect. The results of controlled trials with adequate and inadequate/unclear concealment of allocation sometimes differed. When differences occurred, most often trials with inadequate or unclear allocation concealment yielded larger estimates of effects relative to controlled trials with adequate allocation concealment. However, it is not generally possible to predict the magnitude, or even the direction, of possible selection biases and consequent distortions of treatment effects from studies with non-random allocation or controlled trials with inadequate or unclear allocation concealment.

摘要

背景

随机试验利用随机化过程将参与者分配到各个比较组。如果该过程未被破坏,其不可预测性应能防止比较组之间出现系统性差异(选择偏倚)。因随机因素导致的差异仍会出现,通过对足够多的人进行随机化可将这些差异降至最低。

目的

评估随机化及分配方案隐藏对医疗保健研究结果的影响。

检索策略

我们检索了Cochrane方法学注册库、MEDLINE、SciSearch以及截至2009年9月的参考文献列表。此外,我们筛选了引用纳入研究的文章(ISI科学引文索引)以及与纳入研究相关的论文(PubMed)。

选择标准

符合条件的研究设计包括队列研究、医疗保健干预措施的系统评价或荟萃分析,这些研究比较了随机分配与非随机分配,或随机试验中分配方案隐藏充分与不充分/不明确的情况。感兴趣的结局包括效应估计值的大小和方向以及预后因素的不均衡性。

数据收集与分析

我们独立检索并评估了似乎符合纳入标准的研究。至少两名综述作者独立评估方法学质量并提取信息。我们为每个比较准备了结果的表格总结,并对各项研究的结果进行定性评估,以确定共同趋势或差异。

主要结果

共有18项研究(系统评价或荟萃分析)符合我们的纳入标准。其中10项比较了随机分配与非随机分配,9项比较了对照试验中分配方案隐藏充分与不充分或不明确的情况。所有研究都存在较高的偏倚风险。对于随机研究与非随机研究的比较,四项比较结果不明确(不同结局或不同分析模式之间存在差异);三项比较显示随机分配与非随机分配结果相似;两项比较显示非随机研究中的效应估计值大于随机试验;两项比较显示随机研究中的效应估计值大于非随机研究。五项研究发现分配方案隐藏不充分的试验中的效应估计值大于分配方案隐藏充分的试验。其他四项研究未发现统计学上的显著差异。

作者结论

随机研究与非随机研究的结果有时存在差异。在某些情况下,非随机研究的效应估计值更大,而在其他情况下,随机试验的效应估计值更大。分配方案隐藏充分与不充分/不明确的对照试验结果有时也存在差异。当出现差异时,大多数情况下,分配方案隐藏不充分或不明确的试验相对于分配方案隐藏充分的对照试验,效应估计值更大。然而,通常无法预测非随机分配研究或分配方案隐藏不充分或不明确的对照试验中可能存在的选择偏倚的大小,甚至方向,以及由此导致的治疗效果扭曲。

相似文献

1
Randomisation to protect against selection bias in healthcare trials.随机化以防止医疗保健试验中的选择偏倚。
Cochrane Database Syst Rev. 2011 Apr 13;2011(4):MR000012. doi: 10.1002/14651858.MR000012.pub3.
2
Randomisation to protect against selection bias in healthcare trials.随机化以防止医疗保健试验中的选择偏倚。
Cochrane Database Syst Rev. 2007 Apr 18(2):MR000012. doi: 10.1002/14651858.MR000012.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Interventions to improve inhaler technique for people with asthma.改善哮喘患者吸入器使用技术的干预措施。
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD012286. doi: 10.1002/14651858.CD012286.pub2.
7
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
8
Interventions for paracetamol (acetaminophen) overdose.对乙酰氨基酚过量的干预措施。
Cochrane Database Syst Rev. 2018 Feb 23;2(2):CD003328. doi: 10.1002/14651858.CD003328.pub3.
9
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
10
Interventions for infantile haemangiomas of the skin.皮肤婴儿血管瘤的干预措施。
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD006545. doi: 10.1002/14651858.CD006545.pub3.

引用本文的文献

1
ChatGPT as a Learning Tool for Medical Students: Results From a Randomized Controlled Trial.ChatGPT作为医学生的学习工具:一项随机对照试验的结果
Cureus. 2025 Jun 11;17(6):e85767. doi: 10.7759/cureus.85767. eCollection 2025 Jun.
2
SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.《SPIRIT 2025解释与阐述:随机试验方案更新指南》
BMJ. 2025 Apr 28;389:e081660. doi: 10.1136/bmj-2024-081660.
3
Opportunities and challenges to delivering a trial for depressive symptoms in primary care during the COVID-19 pandemic: insights from the Alpha-Stim-D randomised controlled trial.在新冠疫情期间开展基层医疗中抑郁症状试验的机遇与挑战:来自Alpha-Stim-D随机对照试验的见解
Trials. 2025 Feb 20;26(1):62. doi: 10.1186/s13063-025-08772-3.
4
Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials.用于口服抗凝相关严重出血患者口服抗凝剂逆转的凝血酶原复合物浓缩剂:随机临床试验的系统评价
Scand J Trauma Resusc Emerg Med. 2025 Feb 4;33(1):19. doi: 10.1186/s13049-025-01334-1.
5
The evolution of selection bias in the recent epidemiologic literature-a selective overview.近期流行病学文献中选择偏倚的演变——选择性概述。
Am J Epidemiol. 2025 Mar 4;194(3):580-584. doi: 10.1093/aje/kwae282.
6
Effects of Pea () Prebiotics on Intestinal Iron-Related Proteins and Microbial Populations In Vivo ().豌豆()益生元对体内肠道铁相关蛋白和微生物种群的影响()。
Nutrients. 2024 Jun 13;16(12):1856. doi: 10.3390/nu16121856.
7
Drug trials are more likely to disclose full placebo control information than non-drug trials: A cross-sectional study of participant information leaflets of placebo-controlled trials.与非药物试验相比,药物试验更有可能披露完整的安慰剂对照信息:一项对安慰剂对照试验参与者信息手册的横断面研究。
Integr Med Res. 2024 Jun;13(2):101043. doi: 10.1016/j.imr.2024.101043. Epub 2024 Apr 17.
8
Application of the Composite Quality Score (CQS-2B) versus Cochrane's Risk of Bias tool (Version 2) in systematic reviews of clinical trials - an exploratory study.复合质量评分(CQS - 2B)与Cochrane偏倚风险工具(第2版)在临床试验系统评价中的应用——一项探索性研究。
Front Med (Lausanne). 2024 May 2;11:1307815. doi: 10.3389/fmed.2024.1307815. eCollection 2024.
9
To weight or not to weight? The effect of selection bias in 3 large electronic health record-linked biobanks and recommendations for practice.是否要进行体重测量?3 个大型电子健康记录相关生物库中的选择偏倚效应及其实践建议。
J Am Med Inform Assoc. 2024 Jun 20;31(7):1479-1492. doi: 10.1093/jamia/ocae098.
10
Engagement in GI Behavioral Health Is Associated with Reduced Portal Messages, Phone Calls, and ED Visits.参与胃肠道行为健康与减少门户消息、电话和急诊就诊相关。
Dig Dis Sci. 2024 Jun;69(6):1939-1947. doi: 10.1007/s10620-024-08428-3. Epub 2024 Apr 15.

本文引用的文献

1
Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials.手术操作的精心设计的非随机对照研究的荟萃分析与随机对照试验一样好。
J Clin Epidemiol. 2010 Mar;63(3):238-45. doi: 10.1016/j.jclinepi.2009.04.005. Epub 2009 Aug 27.
2
Trial sample size, but not trial quality, is associated with positive study outcome.试验样本量,但不是试验质量,与阳性研究结果相关。
J Clin Epidemiol. 2010 Feb;63(2):154-62. doi: 10.1016/j.jclinepi.2009.05.007. Epub 2009 Aug 27.
3
ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation.ACE(I/D)基因多态性与冠状动脉疾病治疗反应:一项涉及研究质量评估的综合数据库及荟萃分析
BMC Med Genet. 2009 Jun 4;10:50. doi: 10.1186/1471-2350-10-50.
4
Evidence in the era of globalization. Abstracts of the 16th Cochrane Colloquium. October 3-7, 2008. Freiburg, Germany.
Z Evid Fortbild Qual Gesundhwes. 2008;102 Suppl 6:7-99.
5
Meta-analysis of randomized and controlled treatment trials for achalasia.贲门失弛缓症随机对照治疗试验的荟萃分析。
Dig Dis Sci. 2009 Nov;54(11):2303-11. doi: 10.1007/s10620-008-0637-8. Epub 2008 Dec 24.
6
Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.更正:在荟萃分析中报告的方法学质量以及大型和小型随机试验之间的差异。
Ann Intern Med. 2008 Aug 5;149(3):219. doi: 10.7326/0003-4819-149-3-200808050-00023.
7
STREPTOMYCIN treatment of pulmonary tuberculosis.链霉素治疗肺结核。
Br Med J. 1948 Oct 30;2(4582):769-82.
8
The effect of bias on the magnitude of clinical outcomes in periodontology: a pilot study.偏倚对牙周病学临床结局大小的影响:一项试点研究。
J Clin Periodontol. 2008 Sep;35(9):775-82. doi: 10.1111/j.1600-051X.2008.01291.x.
9
Quality of surgical randomized controlled trials for acute cholecystitis: assessment based on CONSORT and additional check items.急性胆囊炎外科随机对照试验的质量:基于CONSORT及附加检查项目的评估
J Hepatobiliary Pancreat Surg. 2008;15(3):297-303. doi: 10.1007/s00534-007-1268-8. Epub 2008 Jun 6.
10
A meta-regression analysis shows no impact of design characteristics on outcome in trials on tension-type headaches.一项Meta回归分析显示,在紧张型头痛试验中,设计特征对结果没有影响。
J Clin Epidemiol. 2008 Aug;61(8):813-8. doi: 10.1016/j.jclinepi.2007.10.006. Epub 2008 Mar 24.